Valley Stream, New York Clinical Trials

A listing of Valley Stream, New York clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 96 clinical trials
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

The purpose of this study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the time to the first clinical events committee (CEC)-adjudicated morbidity or mortality (M/M) event in participants with symptomatic pulmonary arterial hypertension (PAH) compared to macitentan 10 mg.

heart disease
ventricular septal defect
macitentan
macitentan 10 mg
ventricular septal defects
Winthrop University Hospital
 (6.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +210 other locations
Phase 2 Study of SAR439859 Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer (AMEERA-3)

Primary Objective: To determine whether SAR439859 per os improves progression free survival (PFS) when compared with a endocrine monotherapy of the choice of the physician, in participants with metastatic or locally advanced breast cancer. Secondary Objectives: To compare the overall survival in the 2 treatment arms To assess the objective …

targeted therapy
estrogen receptor-positive breast cancer
endocrine therapy
er-positive breast cancer
metastasis
Investigational Site Number 8400009
 (5.3 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +125 other locations
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease  

This is a multicenter, randomized, double-blind, placebo-controlled study that will evaluate the efficacy and safety of intravenous (IV) prasinezumab versus placebo in participants with Early Parkinson's Disease (PD) who are on stable symptomatic PD medication.

bradykinesia
tremor
dopamine
parkinsonism
early parkinson's
Neuroscience Institute at Great Neck
 (7.7 away)
  • 0 views
  • 28 Jun, 2022
  • +125 other locations
A Multicenter Randomized Phase III Trial on INTraoperative RAdiotherapy in Newly Diagnosed GliOblastoma Multiforme (INTRAGO II) (INTRAGO-II)

INTRAGO II resembles a multicentric, prospective, randomized, 2-arm, open-label clinical phase III trial which tests if the median progression-free survival (PFS) of patients with newly diagnosed glioblastoma multiforme (GBM) can be improved by the addition of intraoperative radiotherapy (IORT) to standard radiochemotherapy.

Long Island Jewish Medical Center, North Shore University Hospital
 (5.7 away) Contact site
  • 0 views
  • 20 Jul, 2022
  • +16 other locations
Test_question

test

Accepts healthy volunteers
SiteQ7
 (3.6 away) Contact site
  • 0 views
  • 14 Dec, 2022
  • 1 location
MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment

In spinal cord tumors requiring surgical intervention, the resection difficulty is determined by two significant factors: tumor stiffness and adhesion to surrounding tissue. The stiffness of the tumor dictates the complexity of removal, while strong adhesion presents additional challenges during the surgical procedure. This clinical trial aims to assess the …

Accepts healthy volunteers
Site 001
 (3.6 away) Contact site
  • 0 views
  • 25 Jul, 2023
  • +21 other locations
end date passed (end date passed)

end date passed

“>
 (3.6 away) Contact site
  • 0 views
  • 14 Mar, 2024
  • 1 location
A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer

This study is being done to find out if delivering gemcitabine using the ACT-IOP-003 device directly to the area where the tumor is in the pancreas is safe and tolerable.The main questions the study aims to answer are:Is ACT-IOP-003 safe and tolerable when given to patients with nonmetastatic, locally advanced, …

New York Medical and Diagnostic Center
 (7.0 away) Contact site
  • 0 views
  • 21 Mar, 2026
  • +2 other locations
BS01 in Patients With Retinitis Pigmentosa

Non-randomized, open label, Phase 1/2 dose escalation study of BS01, a non-replicating, rep/cap-deleted, recombinant adeno-associated virus vector expressing an enhanced light-sensitive channelrhodopsin gene (ChronosFP).

retinitis
OCLI
 (4.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

This study will test the safety of Quad Shot radiation therapy using 2 different treatment schedules to find out what effects, if any, this treatment has on people with advanced NSCLC who are receiving systemic therapy for their cancer. The Quad Shot treatment schedule reduces the number of days needed …

paclitaxel
hemoptysis
metastasis
pembrolizumab
carboplatin/paclitaxel
Memorial Sloan Kettering Nassau (All protocol activities)
 (6.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +6 other locations